We are in the process of testing our hypothesis: inhibiting BIRC5 expression suppresses tumor metastasis in an orthotopic ovarian cancer mouse model by using selective small molecule survivin inhibitors. This evidence concerns the gene BIRC5 and ovarian cancer.